You have a Small Micro-Papillary Thyroid Cancer and don’t want surgery and do not like the two options your physicians offer. Also do not want the cancer in your neck for long term active surveillance:

You have a Small Micro-Papillary Thyroid Cancer and don’t want surgery and do not like the two options your physicians offer. Also do not want the cancer in your neck for long term active surveillance:

You have a Small Micro-Papillary Thyroid Cancer and don’t want surgery and do not like the two options your physicians offer. Also do not want the cancer in your neck for long term active surveillance:

You have a Small Micro-Papillary Thyroid Cancer and don’t want surgery and do not like the two options your physicians offer. Also do not want the cancer in your neck for long term active surveillance:

Percutaneous Ethanol Injection PEI for Primary Papillary Thyroid Microcarcinoma

 Purpose: Private center to treat micro-papillary cancers with ethanol. This is in place of surgery or long term active surveillance with the cancer still in the thyroid gland.

Patients that will undergo percutaneous ethanol ablation for the management of papillary thyroid microcarcinoma.

  • Drug: percutaneous ethanol ablation
    The volume of 99% ethanol to be injected is calculated using a standardized formula. Ethanol is instilled with a needle under ultrasound guidance after administration of local anesthesia.

 Percutaneous ethanol ablation (PEI) for primary papillary thyroid microcarcinoma (PTMC) has equivalent oncologic outcomes to current treatment options including observation, thyroid lobectomy and total thyroidectomy.

PEI it may yield superior long-term quality of life, including measures of pain, voice, and cosmesis than standard surgical therapy (total thyroidectomy). PEI Studies at the Mayo clinic

248cdd01

img_0625

by Ian Hay and with radio frequency ablation RFA in Korea by Professor JH Baek

 

baek

have shown the favorable results with these minimally invasive procedures.

Age 18 years and older

Diagnosis: single, cytology-proven papillary thyroid carcinoma measuring 1.5 cm or less in diameter (microcarcinoma, T1a), without visible extrathyroidal extension, and with negative central and lateral neck lymph nodes by ultrasound

Exclusions:

  • Patient refusal to participate
  • History of prior thyroid or parathyroid surgery
  • Previous recurrent laryngeal nerve injury
  • Inability to make decisions or comply with follow up
  • Co-existing indication for thyroidectomy
  • Aggressive cytological or molecular features
  • Multifocal papillary thyroid carcinoma
  • Pregnant or breast-feeding
  • Anatomically unfavorable location of the tumor (proximity to recurrent laryngeal nerve or trachea)
  • Documented or suspected distant metastasis
  • History of radiation to neck or face
  • Family history of thyroid cancer

If you are interested in this approach to treatment compared to surgery or long time observation, call Matt at 310-393-8860 or thyroid.manager@protonmail.com. 

This is not a research study but a alternative treatment provided at a private thyroid cancer center.

Richard Guttler MD,FACE,ECNU

www.thyroid.com

Add Your Comment

Contact Info
1328 16th Street, Santa Monica, CA 90404
Monday – Friday
9:00 AM to 5:00 PM
(310) 393-8860